Mission and Vision
The Princess Margaret (PM) Leukemia Biobank has played a seminal role in all our discoveries in leukemia stem cell biology over the past 30 years. It has simply been an outstanding resource.
Canada Research Chair in Stem Cell Biology, Senior Scientist, Princess Margaret Cancer Centre, University Health Network; Professor, Department of Molecular Genetics, University of Toronto; Co-Director, Translational Research Initiative in Leukemia, Ontario Institute for Cancer Research (OICR)
The Leukemia Tissue Bank at Princess Margaret Cancer Centre (PM), University Health Network (UHN) collects and stores samples from consented patients with a variety of hematologic disorders and other malignancies including, but not limited to: Acute Myeloblastic Leukemia (AML), Acute Lymphoblastic Leukemia (ALL), Chronic Myelogenous Leukemia (CML), Chronic Lymphocytic Leukemia (CLL), Myeloproliferative Syndromes, Myelodysplastic Syndromes, Hairy Cell Leukemia, Sezary Syndrome, Multiple Myelomas and Lymphomas.
We provide high quality samples that include viable cells, plasma and serum, with associated clinical data to qualified researchers within UHN, at academic centres around the world and to industry. Our ultimate goal is to improve the prevention, diagnosis and treatment of blood disorders and other malignancies by facilitating studies that will enhance our understanding of the diseases.
Leukemia Tissue Bank
Princess Margaret Cancer Centre / University Health Network
610 University Avenue, 9th Floor
Toronto, Ontario, Canada